Literature DB >> 2964318

Sebum production is increased in Behçet's syndrome and even more so in rheumatoid arthritis.

H Yazici1, C Mat, S Deniz, A Iscimen, S Yurdakul, Y Tuzun, N Hekim, Y Yazici.   

Abstract

Sebum production is under hormonal control. We had shown that male sex is associated with more severe disease in Behçet's syndrome and the acneiform skin lesion of this disorder is not different from ordinary acne, an androgen-dependent lesion. Sebum excretion rate was higher in patients with Behçet's syndrome than in healthy controls, children and patients with ankylosing spondylitis. On the other hand, patients with rheumatoid arthritis had high levels of sebum excretion rate comparable to those found in patients with acne vulgaris. These suggest the presence of a sebotrophic hormone and/or other hormonal effects in Behçet's syndrome and rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2964318

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

Review 1.  Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors:  H Direskeneli
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

2.  Effect of surgical cleaning of the skin on the pathergy phenomenon in Behçet's syndrome.

Authors:  I Fresko; H Yazici; M Bayramiçli; S Yurdakul; C Mat
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

3.  Application of sebomics for the analysis of residual skin surface components to detect potential biomarkers of type-1 diabetes mellitus.

Authors:  Satyajit S Shetage; Matthew J Traynor; Marc B Brown; Thomas M Galliford; Robert P Chilcott
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

4.  Sebomic identification of sex- and ethnicity-specific variations in residual skin surface components (RSSC) for bio-monitoring or forensic applications.

Authors:  Satyajit S Shetage; Matthew J Traynor; Marc B Brown; Robert P Chilcott
Journal:  Lipids Health Dis       Date:  2018-08-21       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.